1xbet 로그인., Ltd.
Pharmaceuticals
September 28, 2016
1xbet 로그인®1xbet 로그인, a New Treatment for Glaucoma and Ocular Hypertension
- Mikeluna 1xbet 로그인 is an Otsuka-developed eye drop containing a combination of the non-selective β-blocker cartelol hydrochloride and the prostaglandin analogue latanoprost.
- Usually glaucoma is treated initially with a single therapeutic agent and if intraocular pressure is not c1xbet 로그인trolled sufficiently then additi1xbet 로그인al agents are prescribed. However, the requirement to wait between applicati1xbet 로그인s of each eye drop may reduce the efficacy of the treatment as dose adherence often decreases. A combinati1xbet 로그인 of the two into 1xbet 로그인e formulati1xbet 로그인 would improve adherence.
1xbet 로그인., Ltd. on September 28, 2016 obtained regulatory approval in Japan for the manufacture and marketing of Mikeluna combination ophthalmic solution for glaucoma and intraocular hypertension. The drug will be co-promoted with Senju Pharmaceutical Co., Ltd.